Avalere Health Essential Voice: Recent Episodes
Avalere Health
Twenty years ago, Avalere Health set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to listen to our experts discuss the hot topics that you need to track.
Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.
Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.
Tune into the third episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the future of RSV among older adults.
Tune into the second episode in our miniseries focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss RSV prevention products currently in development, specifically maternal immunizations and pediatric vaccines.
Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.
Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.
Tune into the third episode in the Avalere Health Essential Voice podcast series focused on Agency decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs) by considering how potential policy and market catalysts 3 to 5 years out may help stakeholders think through opportunities and risks at key decision points ranging from early in development to implications for Part D.
Tune into the third episode in the Avalere Health Essential Voice podcast series focused on Agency decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs) by considering how potential policy and market catalysts 3 to 5 years out may help stakeholders think through opportunities and risks at key decision points ranging from early in development to implications for Part D.
Tune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS’s evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclonal antibodies for Alzheimer's disease as an example.
Tune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.
In the third and final episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share insights on disparities in kidney care.
Listen to previous episodes in this series:
- Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems
- Exploring the Kidney Care Environment, Part II, Policy and Payment Trends
In the second episode of the Avalere Health Essential Voice miniseries focused on kidney care, our experts share their perspective on policy and payment trends.
Listen to previous episodes in this series:
- Exploring the Kidney Care Environment: Key Players, Treatment, and Payment Systems
In this episode of Avalere Health Essential Voice, we kick off our miniseries focused on the evolving kidney care landscape.
In this episode of the Avalere Health Essential Voice, we welcome leaders from the National Alliance of State & Territorial AIDS Directors (NASTAD) to discuss state HIV policies and barriers to ending the HIV epidemic in the US.
In this episode of the Avalere Health Essential Voice, we welcome Carl Schmid, Executive Director at the HIV + Hepatitis Policy Institute, to commemorate World AIDS Day on December 1.
In this episode of Avalere Health Essential Voice, our experts continue their discussion on channel strategy development for bringing a drug to market.
Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
Tune into Part 2 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-ii
In this episode of Avalere Health Essential Voice, our experts welcome leaders from Gilead Sciences and Jazz Pharmaceuticals to discuss channel distribution strategy.
Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
In this episode of Avalere Health Essential Voice, the fifth and final in our Medicare Part D miniseries, our experts discuss the Center for Medicare & Medicaid Innovation (CMMI) and where we can anticipate some activity in the coming year, particularly as it relates to the Part D program.
In this episode of Avalere Health Essential Voice, the fourth in our Medicare Part D miniseries, our experts discuss key elements of the legislative process including budget neutrality and congressional scoring.
In this episode of Avalere Health Essential Voice, the third in our Medicare Part D miniseries, our experts discuss policy changes and the impact on market access.
In this episode of Avalere Health Essential Voice, the second in our Medicare Part D miniseries, our experts discuss how health plans make decisions within Part D.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the need for patient support in cell and gene therapies and the ways in which various stakeholders provide it.
In this episode of Avalere Health Essential Voice, the first in our Medicare Part D miniseries, our experts discuss Part D trends and pressures in the evolving drug pricing environment.
In this episode of Avalere Health Essential Voice, our experts discuss what they expect to see from a legislative perspective this fall on Capitol Hill.
In this episode of Avalere Health Essential Voice, our experts discuss the forthcoming debate around the coverage gap for individuals residing in states that have not participated in Medicaid expansion.
In this episode of Avalere Health Essential Voice, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the use of third-party logistics companies for distribution, warehousing, and fulfillment in biopharma.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss Huntington’s Disease through the lens of its symptoms, challenges, and potential treatment.
In this episode of Start Your Day with Avalere, Chris Johnson of Landmark Health joins us to discuss his organization’s experience as an early participant in CMMI’s Direct Contracting payment model.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the challenges surrounding cell and gene therapies from both the patient and payer perspective.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a study on the impact of Medicaid expansion on coverage and care for women of reproductive age.
In this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the final session in our 3-part series on infusing the patient perspective into value assessment.
In this episode of the Avalere Health Essential Voice Disease Education Series, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the state of oncology care from a provider and a patient perspective as we continue to look at the impact of COVID-19 and prepare for post-pandemic realities.
In this episode of Start Your Day with Avalere, our policy experts discuss healthcare price transparency efforts and the anticipated impact of making previously confidential pricing information public.
In this episode of Avalere Health Essential Voice in our Start Your Day with Avalere series, our experts return for the second of a three-part series on infusing the patient perspective into value assessment.
In this episode of Avalere Health Essential Voice, experts from our Market Access practice discuss major takeaways from the 2021 National Comprehensive Cancer Network annual conference.
In this episode of the Avalere Health Essential Voice Start Your Day with Avalere series, our experts kick off a three-part series on incorporating the patient perspective in value assessment.
In this episode of our Avalere Health Essential Voice Disease Education series, experts from our Center for Healthcare Transformation discuss the prevalence of malnutrition, its impact on the healthcare system, and the Avalere-led quality improvement initiative created to address it.
Tune in to the replay of our webinar, Understanding Shifting Insurance Coverage Impacts to hear Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers.
As a result of the COVID-19 pandemic and associated economic downturn, millions of Americans have lost employer-sponsored insurance and have either enrolled in publicly subsidized coverage or become uninsured. Healthcare stakeholders will need to adapt to these changes and consider site-of-care policies and reimbursement, evolution of benefit structure, patient and provider access and support programs, and cost-sharing implications.
Key Topics * Coverage shift causes and trends * Care delivery impacts (physicians and health plan coverage of services) * New variables for consumer plan choices * Payer responses and policy change * Patient access and support * Ancillary support strategies * Potential congressional action affecting coverage
This webinar was recorded on March 17, 2021.
In this episode of Avalere Health Essential Voice, President and CEO of Tivity Health, Richard Ashworth, joins us to discuss the impact of COVID-19 on seniors’ health and wellbeing, and how this population’s attitude toward the COVID vaccine continues to evolve.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent analysis of birth centers as an enhanced, evidence-based care model in CMS’s Strong Start initiative.
Tune in to the replay of our webinar, COVID-19: Lessons Learned and the Path Forward to hear Avalere’s panel of policy, public health, and regulatory experts discuss the challenges, opportunities, and key milestones to watch.
As we near the 1-year COVID-19 pandemic declaration, new issues and questions emerge for healthcare industry stakeholders. COVID-19 has significantly altered traditional approaches. It has also accelerated change and further exposed challenges within our system. During this webinar, Avalere experts will discuss how the pandemic has transformed healthcare and what these changes will mean going forward.
Key Topics
- Exploring FDA pathway developments
- Understanding COVID-19 vaccine challenges
- Examining overall vaccine market implications
- Advancing evidence generation strategies
- Elevating the importance of health equity
This webinar was recorded on February 24, 2021.
In this episode of Avalere Health Essential Voice focused on disease education, experts from our Market Access practice discuss support programs designed for rare disease patients, caregivers, and providers, particularly in light of the continued impact of COVID-19 on the patient population.
In this episode of Avalere Health Essential Voice, we welcome nutrition experts to discuss the use of telehealth in providing nutrition care during the pandemic, as well as future barriers and opportunities in virtual care.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on how food labeling affects consumption.
This episode is based on findings from an article published on PubMed.gov: Smart Food Policy for Healthy Food Labeling: Leading With Taste, Not Healthiness, to Shift Consumption and Enjoyment of Healthy Foods
In this episode of Avalere Health Essential Voice, our experts discuss recent research focused on patients who received CAR T-cell therapy for large B-cell lymphoma (LBCL) using Medicare fee-for-service claims data.
On January 7, 2021, Sarah Butler led 4 panel discussions exploring the key healthcare questions for the upcoming year and evidence-based strategies for life sciences companies, health plans, and providers to overcome potential access barriers and improve health outcomes.
Download the 2021 Avalere Healthcare Industry Outlook document. The archived video of the webinar will be available soon.
Key Topics * Navigating the post-election policy landscape, including the COVID-19 pandemic, health disparities, drug pricing, and access to healthcare coverage * Addressing patient affordability, drug pricing, the role of Center for Medicare & Medicaid Innovation * Using data and innovative care models to address healthcare disparities, public health issues, and the consequences of delayed and deferred care * Understanding the emerging COVID-19 vaccines and therapeutics marketplace and the role of the Food & Drug Administration
In this episode of Avalere Health Essential Voice, experts from nutrition service organizations discuss the growing importance of medically tailored meals (MTM) in addressing food insecurity and poor health for medically complex individuals.
In this episode of Get the Facts on COVID-19, Avalere vaccines experts discuss state distribution plans for existing and future COVID-19 vaccines.
In this episode of Avalere Health Essential Voice Journal Club Review, our experts discuss the findings, themes, and relevant application of a recent study on disparities in the health development of young children.
In this episode of Start Your Day with Avalere, our experts discuss how telehealth has evolved during the pandemic and where they believe the sector is headed.
In this episode of Start Your Day with Avalere, our policy experts discuss the Most Favored Nation (MFN) drug pricing model due to begin on January 1.
In Part 2 of this episode focused on social determinants of health (SDOH), Avalere experts discuss how life sciences companies are recognizing the importance of SDOH data and its impact on intervention development.
In this episode of Start Your Day with Avalere, our experts discuss the mechanisms behind CMS’s direct contracting payment model and its future outlook.
In Part 1 of this episode of Avalere Health Essential Voice focused on social determinants of health (SDOH), our experts discuss the importance of SDOH data in research, how health plans are utilizing that data, and the limitations that surround data access.
Tune in to the replay of our webinar, 2020 Election with Avalere: What's at Stake for Healthcare Post-Election?, to hear Avalere experts discuss how the 2020 election is influencing the future of healthcare.
COVID-19, the Affordable Care Act (ACA), and drug-pricing reform have taken center stage in the healthcare debate this past year. Join our experts to find out how the 2020 election could bring about major changes influencing the future of healthcare. This includes implications of a Biden administration or second-term Trump presidency, and an assessment of the new composition of the Senate.
Key Topics
- COVID-19
- ACA
- Drug-pricing reform
- Medicare and Medicaid
- Healthcare disparities
This webinar was recorded on November 5, 2020. Please forgive any technical difficulties. With increased bandwidth requirements of virtual meetings, the audio quality can be impacted.
In this episode of the Avalere Health Essential Voice 2020 Election series, our experts discuss the impact of the COVID surge on the campaigns’ closing arguments, the current outlook on a relief package, and how the election results will affect individual stakeholders, hours before returns begin to come in.
In this episode of Avalere Health Essential Voice Journal Club Review, our policy experts discuss the findings, themes, and relevant application of a recent study on whether pull funding for a COVID-19 vaccine could overcome issues related to speed, scaling, and pricing.
In this episode of Avalere Health Essential Voice, our experts discuss what health plans need to know about social determinants of health data, specifically, the different types of data, what to do with them, and how to fairly assess the impact of social risks on health outcomes.
In this episode of Avalere Health Essential Voice, our policy experts discuss the potential expansion of public healthcare programs following the 2020 election.
In this episode of Start Your Day with Avalere, our experts discuss the key steps for an effective Medicaid procurement, or re-procurement, response.
In this episode of the Avalere Health Essential Voice: 2020 Election series, our experts discuss the evolving makeup of the Supreme Court and the outlook on California vs. Texas — the upcoming Supreme Court case regarding the constitutionality of the Affordable Care Act and, in particular, the individual mandate.
In this episode of Avalere Health Essential Voice, our policy experts discuss top healthcare issues and platforms from the first Presidential debate, including the Affordable Care Act (ACA), COVID-19, public health, health disparities, and drug-pricing reform.
Tune in to the replay of Part 2 of our Avalere Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.
Recent pricing and policy developments may create major shifts in plan design and preparation. Join our policy and market access experts to evaluate forward-leaning considerations and perspectives for how to best prepare for these developments and adapt your business strategies.
Key Topics * Executive orders related to drug pricing (e.g., rebate rule, importation, international pricing index, 340B) * State-level regulation and legislation * CMS’s proposed value-based purchasing rule: possible impact on manufacturers, healthcare plans, and PBMs * COVID-19 impacts and coverage shifts
This webinar was recorded on September 22, 2020.
In this episode of Avalere Health Essential Voice, experts from our market access and policy teams discuss the different approaches to drug-pricing policies ahead of the 2020 election.
Tune in to the replay of Part 1 of our Avalere Market Access Enablement Strategies webinar series to learn how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.
From value, evidence, and pricing to access, coverage, and reimbursement to insights and commercialization strategy, the COVID-19 pandemic has created new challenges for innovative life sciences companies to bring products to market. Join our experts to learn about the approaches that can be taken in this virtual era to support stakeholder engagement and patient uptake.
Key Topics
- Pre-/post-launch planning
- Third-party channel and distribution
- Patient access strategy
- Customer models and engagement
This webinar was recorded on September 18, 2020.
In this episode of Avalere Health Essential Voice Journal Club Review, our policy experts discuss the findings, themes, and relevant application of a recent study on the degree to which statewide face mask mandates contribute to a reduction in the spread of COVID-19.
In this episode of Start Your Day with Avalere, our Market Access experts continue their discussion on clinical pathways in the context of value in oncology.
In this episode of Avalere Health Essential Voice, experts from Avalere and the Washington State Department of Health continue the discussion on social determinants of health (SDOH), focusing on maternal and child health in the context of public health programs, healthcare access, and health outcomes.
In this episode of Avalere Health Essential Voice, experts from our policy and vaccines teams discuss the differences in healthcare platforms ahead of the 2020 election.
In this episode of Avalere Health Essential Voice Journal Club Review, experts from our Center for Healthcare Transformation discuss the findings, themes, and relevant application of a recent study on the correlation between neighborhood racial and economic polarization, hospital of delivery, and severe maternal morbidity.
In this episode of Start Your Day with Avalere, our experts continue the discussion around challenges within the vaccines marketplace, and the gaps in policy and infrastructure that affect uptake.
In this episode of Start Your Day with Avalere, health IT and policy expert Julie Barnes discusses opportunities for health plans amid interoperability rules and lends insight into the potential requirements that lie ahead.
In this episode of Start Your Day with Avalere, our Market Access experts discuss clinical pathways in the context of value in oncology.
In this episode of Start Your Day with Avalere, our experts discuss the vaccines marketplace and efforts to improve vaccine access and uptake among adults.
In this episode of Start Your Day with Avalere, our experts discuss the challenges and opportunities of the forthcoming interoperability rules for health plans.
In the first episode of the 2020 Election series, Avalere experts discuss the role of healthcare in the 2020 election, focusing on healthcare disparities and issues to watch at the Democratic National Convention.
In this episode of the Avalere Health Essential Voice series focused on the Social Determinants of Health (SDOH), Avalere experts discuss strategies for SDOH solutions and how to incorporate them in the manufacturer space.
Avalere’s 2020 Election series started with a webinar on August 11, with our experts covering the current state of play in the 2020 election and the role of healthcare between now and November.
Prior to COVID-19, polling showed that healthcare was a top voter issue. The pandemic has further concentrated the focus on healthcare, highlighting systemic health, and social inequities, and underscoring coverage gaps in our current system. Join our experts to hear their perspectives on the various scenarios that may unfold to prepare for future policy changes.
Key Topics:
- Where the races stand
- COVID-19 and public-health implications
- Coverage landscape (e.g., Medicaid, ACA)
- Drug-pricing policies
- Healthcare disparities
In this episode of Start Your Day with Avalere, our experts discuss the marketplace and outlook for vaccines.
On July 22, 2020, Avalere experts discussed the marketplace for COVID-19 vaccines and therapeutics, including key decision points for regulatory pathways, pricing, and distribution scenarios for optimal US and EX-US market access.
In the first episode of the Social Determinants of Health (SDOH) series, Avalere experts set the stage for how stakeholders are defining SDOH and the impacts of SDOH on health outcomes, specifically when addressing social risks and needs.
In the first episode of Avalere's Journal Club Review, our experts discuss the findings, themes, and relevant application of a contemporary healthcare publication.
In Part 2 of our COVID-19 provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the impacts of COVID-19 on healthcare provider performance specific to exemptions and waivers.
In Part 3 of the COVID-19 provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the impacts of COVID-19 on provider performance-based incentive programs.
In Part 1 of a three-part provider impacts segment, Avalere experts from the Center for Healthcare Transformation will discuss the provider impacts of COVID-19 on measures, specifically related to cardiovascular disease, diabetes, obstetrics and gynecology, and primary care disease management.
On June 11, 2020, Avalere experts explored the future role of telehealth and how organizations can help shape and take advantage of its increased utilization.
On June 9, 2020, Avalere experts hosted a webinar to discuss new data analytics and health economics and outcomes research approaches for evaluating key value-based topics in healthcare, including novel curative therapy affordability and access, alternative payment models, and the increasingly important role of real-world evidence in healthcare decision-making. Tune in to hear the audio version of the webinar.
In the fourth episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Adam Hanauer, Associate Vice President at Humana Specialty Pharmacy, and Mark Sasala, Principal Business Analyst of Products at Creehan & Company, to discuss the outlook of specialty pharmacy with a focus on the environmental considerations and potential impacts of COVID-19.
In the third episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Dr. Colin Edgerton to discuss the specialty pharmacy dynamics with a focus on the provider outlook.
In the second episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Marc Boutin, CEO of the National Health Council, discussing the specialty pharmacy dynamics with a focus on the patient perspective.
In the first episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Joel Wright, CEO at AllianceRx and Ernie Shopes, SVP Products and Client Delivery at Creehan and Company, discussing the outlook for specialty pharmacy, including a focus on trends in the pipeline and overall landscape.
Avalere is committed to the continuous effort for shaping how patients receive care in oncology, during and after COVID-19. In the third episode of our Start Your Day with Avalere podcast series, Avalere's market access and health economics and analytics experts will discuss how healthcare stakeholders are translating clinical evidence to determinations on value.
Avalere is committed to the continuous effort for shaping how patients receive care in oncology, during and after COVID-19. In the second episode of our Start Your Day with Avalere podcast series, Avalere's cell and gene therapy experts will discuss how healthcare stakeholders are considering value when paying for durable therapies.
Avalere is committed to the continuous effort for shaping how patients receive care in oncology, during and after COVID-19.
Timed with ASCO 2020, Avalere's market access and policy experts will discuss how healthcare stakeholders are defining value in oncology.